Date: Tuesday 02 Apr 2013
LONDON (ShareCast) - Afren: Liberum Capital shifts target price from 123p to 130p maintaining a hold recommendation.
Amara Mining: Numis initiates with a target price of 80p and a buy recommendation.
APR Energy: Espirito Santo downgrades to sell with a target price of 680p.
ASOS: Goldman Sachs increases target price from 3600p to 4150p and reiterates a strong buy recommendation.
AstraZeneca: JP Morgan raises target price from 2750p to 3400p and upgrades to neutral.
Berkeley Group: Goldman Sachs ups target price to 2507p, while downgrading from strong buy to buy.
Carnival: Investec reduces target price from 300p to 2800p and retains a buy recommendation.
Dignity: Investec takes target price from 1401p to 1424p, but downgrades from buy to add.
Electrocomponents: Deutsche Bank raises target price from 205p to 230p retaining a hold recommendation.
EnQuest: Liberum Capital moves target price from 153p to 167p and keeps a buy recommendation.
Experian: JP Morgan ups target price from 1210p to 1347p, while its overweight rating remains unchanged.
First Derivatives: Sanlem Securities raises target price from 605p to 700p and retains its buy recommendation.
IMI: Jefferies increases target price from 930p to 1405p keeping a hold recommendation. Goldman Sachs moves target price from 1350p to 1400p, but downgrades to neutral.
National Grid: Societe Generale ups target price from 634p to 674p, but retains a sell recommendation.
Norcros: Numis upgrades to buy with target price of 20p.
Ophir Energy: Credit Suisse reduces target price from 804p to 690p, while retaining an overweight rating.
Petropavlovsk:JP Morgan takes target price from 420p to 460p and keeps an overweight rating.
Premier Farnell: HSBC Holdings downgrades to neutral with a target price of 225p.
QinetiQ: JP Morgan lowers target price from 210p to 205p retaining a neutral rating.
RPC Group: JP Morgan shifts target price from 508p to 512p leaving its overweight rating unchanged.
SIG: Jefferies ups target price from 137p to 185p and maintains a buy recommendation.
Tate & Lyle: Exane BNP moves target price from 800p to 840p reiterating a neutral rating.
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 1,286.00p |
Change Today | -30.00p |
% Change | -2.28 % |
52 Week High | 2,165.00p |
52 Week Low | 812.00p |
Volume | 39,742 |
Shares Issued | 28.17m |
Market Cap | £362.33m |
RiskGrade | 148 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 4 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 5 |
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | 14-Nov-19 | 20-Jun-19 |
Paid | 05-Dec-19 | 19-Jul-19 |
Amount | 8.50p | 19.30p |
Time | Volume / Share Price |
16:35 | 11,372 @ 1,286.00p |
16:35 | 13 @ 1,286.00p |
16:35 | 220 @ 1,286.00p |
16:35 | 30 @ 1,286.00p |
16:35 | 56 @ 1,286.00p |
CEO | Seamus Keating |
Chair | Donna Troy |
CFO | Ryan Preston |
You are here: research